论文信息 - Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or BRCA mutation-associated breast cancer. - 字舞流文

Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or BRCA mutation-associated breast cancer.

H. Linden | P. Porter | E. Swisher | B. Kurland | V. Giranda | J. Gralow | L. Korde | V. Gadi | G. Ellis | X. Chai | J. Specht | E. Rodler | S. Shepherd | R. Yeh | M. Griffin | B. Askovich | J. Hammond | J. Thompson | Reina Hibbert